MENU
+Compare
OTLC
Stock ticker: OTC
AS OF
Apr 3 closing price
Price
$0.05
Change
-$0.01 (-16.67%)
Capitalization
21.63M

OTLC Oncotelic Therapeutics, Inc. Forecast, Technical & Fundamental Analysis

Oncotelic Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for OTLC with price predictions
Apr 03, 2025

OTLC's RSI Oscillator leaves overbought zone

The 10-day RSI Indicator for OTLC moved out of overbought territory on April 01, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 12 instances where the indicator moved out of the overbought zone. In of the 12 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where OTLC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on April 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on OTLC as a result. In of 138 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for OTLC turned negative on April 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 60 similar instances when the indicator turned negative. In of the 60 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OTLC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OTLC broke above its upper Bollinger Band on March 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where OTLC advanced for three days, in of 213 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 105 cases where OTLC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OTLC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.443) is normal, around the industry mean (13.581). P/E Ratio (0.000) is within average values for comparable stocks, (64.662). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.879). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (121.951) is also within normal values, averaging (248.206).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OTLC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
29397 Agoura Road
Phone
+1 650 635-7000
Employees
22
Web
https://www.oncotelic.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVI17.730.16
+0.91%
EVI Industries
BRFS3.470.03
+0.87%
BRF - Brasil Foods SA
MSI435.50-1.49
-0.34%
Motorola Solutions
GEL14.82-1.14
-7.14%
Genesis Energy LP
ALGS6.48-1.10
-14.51%
Aligos Therapeutics Inc

OTLC and Stocks

Correlation & Price change

A.I.dvisor tells us that OTLC and TENX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLC and TENX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLC
1D Price
Change %
OTLC100%
-16.25%
TENX - OTLC
23%
Poorly correlated
-4.76%
MNKD - OTLC
22%
Poorly correlated
-2.79%
IMTX - OTLC
21%
Poorly correlated
-7.91%
MMIRF - OTLC
15%
Poorly correlated
N/A
IUGNF - OTLC
13%
Poorly correlated
N/A
More